Glucotrack, Inc. — Director's Dealing 2025

Oct 8, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Glucotrack, Inc. (GCTK)
CIK: 0001506983
Period of Report: 2025-03-25

Reporting Person: Goode Paul (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-25	Common Stock, par value $0.001 per share	J	42	—	Acquired	339	Direct

Footnotes

F1: On October 7, 2022, the reporting person entered into an into Intellectual Property Purchase Agreement (the "IP Purchase Agreement") with Glucotrack, Inc. (the "Issuer"), pursuant to which the reporting person is entitled to certain specified milestone payments, payable in common stock, par value $0.001 per share, of the Issuer (the "Common Stock"), as set forth in the IP Purchase Agreement. Upon the achievement of the third milestone contemplated by the IP Purchase Agreement, the reporting person was issued 42 shares of Common Stock, pursuant to the terms of the IP Purchase Agreement.